Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Holding(s) in Company

November 26, 2020
RNS Number : 5461G Renalytix AI PLC 26 November 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing

Second Price Monitoring Extn

November 25, 2020
RNS Number : 5327G Renalytix AI PLC 25 November 2020   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension

Price Monitoring Extension

November 25, 2020
RNS Number : 5304G Renalytix AI PLC 25 November 2020   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Financial Results for First Quarter of FY 2021

November 25, 2020
RNS Number : 3896G Renalytix AI PLC 25 November 2020     Renalytix AI plc ("RenalytixAI" or the "Company")   RenalytixAI Reports Financial Results for First Quarter of Fiscal Year 2021   NEW YORK , November 25, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial

RenalytixAI to Participate in the Stifel 2020 Healthcare Conference

November 13, 2020
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today announced the

Stifel 2020 Healthcare Conference

November 13, 2020
RNS Number : 1993F Renalytix AI PLC 13 November 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   RenalytixAI to Participate in the Stifel 2020 Healthcare Conference   NEW YORK , November 13, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled

Change of Adviser

November 6, 2020
RNS Number : 4449E Renalytix AI PLC 06 November 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Change of adviser   NEW YORK , November 6, 2020    - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on

Posting of Annual Report & Accounts and Notice of AGM

November 2, 2020
NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, confirms that the
Displaying 1 - 10 of 141